Post August 25, 2026August 25, 2026not suitable for work Inovio Stock: The Final Countdown To A Binary FDA Decision (NASDAQ:INO) by webmaster Inovio Pharmaceuticals is a single-asset, late-stage biotech, with value hinging on the October 30th PDUFA decision for INO-3107. Learn why INO stock is a hold.